NCT02284997View on ClinicalTrials.gov

The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Meibomian Gland Dysfunction (MGD)
Interventions
DEVICE

MGDRx® EyeBag

Class 1 Medical Device, registered with the Medicines and Healthcare products Regulatory Agency. UK Patent: GB2421687B. The EyeBag is made of silk and 100% brushed black cotton and filled with flax / linseed. When heated, this device is intended to warm the eyelids. This melts the meibum and clears the meibum obstruction of the MGs.

Trial Locations (1)

N2L 3G1

Centre for Contact Lens Research, University of Waterloo, Waterloo

All Listed Sponsors
lead

University of Waterloo

OTHER

NCT02284997 - The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter